Naleya Genomics

Naleya Genomics Indonesia (NGI) is a private company that provides biotechnology-based genomic health screening. We provide the right solution for the importance of prevention regarding personal health, which is currently the governments focus in transforming the Indonesian peoples health. We work with medical professionals and private health support agencies to improve the quality of genomic examination services in Indonesia. Our current development focus in Indonesia is B2B, to become a pioneer and an incubator for genome testing support services based on the latest biotechnology affordable for the people of Indonesia. We are supported by modern laboratory infrastructure that creates new...

Biotechnology,next generation sequencing,laboratory,and health clinic

Naleya genomics operates in the Biotechnology research industry.

Naleya genomics's revenue is 11m - 100m

Naleya genomics has 11 - 50 employees.